Search research articles
Contact Us
Filters
Showing results (161-170 of 224) with videos related to
Page
of 23
Sort By:
American Journal of Physiology. Heart and Circulatory Physiology
|
July 14, 2018
Noninvasive wave intensity analysis predicts functional worsening in children with pulmonary arterial hypertension
Michal Schäfer, Neil Wilson, D Dunbar Ivy, et al.
British Journal of Haematology
|
April 21, 2015
Bendamustine, thalidomide and dexamethasone combination therapy for relapsed/refractory myeloma patients: results of the MUKone randomized dose selection trial
Steve Schey, Sarah R Brown, Avie-Lee Tillotson, et al.
Haematologica
|
May 30, 2015
Four genes predict high risk of progression from smoldering to symptomatic multiple myeloma (SWOG S0120)
Rashid Khan, Madhav Dhodapkar, Adam Rosenthal, et al.
Nature Communications
|
May 16, 2024
1q amplification and PHF19 expressing high-risk cells are associated with relapsed/refractory multiple myeloma
Travis S Johnson, Parvathi Sudha, Enze Liu, et al.
The British Journal of Radiology
|
February 27, 2016
Recommendations for accurate CT diagnosis of suspected acute aortic syndrome (AAS)--on behalf of the British Society of Cardiovascular Imaging (BSCI)/British Society of Cardiovascular CT (BSCCT)
Varut Vardhanabhuti, Edward Nicol, Gareth Morgan-Hughes, et al.
Leukemia & Lymphoma
|
November 15, 2011
MyelomA Genetics International Consortium
Gareth Morgan, Hans Erik Johnsen, Hartmut Goldschmidt, et al.
Blood Cancer Journal
|
August 12, 2024
Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm
Charlotte Pawlyn, Fredrik H Schjesvold, David A Cairns, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 25, 2010
Phase I/II clinical study of Tosedostat, an inhibitor of aminopeptidases, in patients with acute myeloid leukemia and myelodysplasia
Bob Löwenberg, Gareth Morgan, Gert J Ossenkoppele, et al.
Blood Advances
|
August 17, 2022
Characterizing the role of the immune microenvironment in multiple myeloma progression at a single-cell level
Carolina Schinke, Alexandra M Poos, Michael Bauer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 23, 2024
Genomic Profiling to Contextualize the Results of Intervention for Smoldering Multiple Myeloma
Dickran Kazandjian, Benjamin Diamond, Marios Papadimitriou, et al.
Page
of 23
Search research articles
Search
Showing results (161-170 of 224) with videos related to
Sort By:
Page
of 23
American Journal of Physiology. Heart and Circulatory Physiology
|
July 14, 2018
Noninvasive wave intensity analysis predicts functional worsening in children with pulmonary arterial hypertension
Michal Schäfer, Neil Wilson, D Dunbar Ivy, et al.
British Journal of Haematology
|
April 21, 2015
Bendamustine, thalidomide and dexamethasone combination therapy for relapsed/refractory myeloma patients: results of the MUKone randomized dose selection trial
Steve Schey, Sarah R Brown, Avie-Lee Tillotson, et al.
Haematologica
|
May 30, 2015
Four genes predict high risk of progression from smoldering to symptomatic multiple myeloma (SWOG S0120)
Rashid Khan, Madhav Dhodapkar, Adam Rosenthal, et al.
Nature Communications
|
May 16, 2024
1q amplification and PHF19 expressing high-risk cells are associated with relapsed/refractory multiple myeloma
Travis S Johnson, Parvathi Sudha, Enze Liu, et al.
The British Journal of Radiology
|
February 27, 2016
Recommendations for accurate CT diagnosis of suspected acute aortic syndrome (AAS)--on behalf of the British Society of Cardiovascular Imaging (BSCI)/British Society of Cardiovascular CT (BSCCT)
Varut Vardhanabhuti, Edward Nicol, Gareth Morgan-Hughes, et al.
Leukemia & Lymphoma
|
November 15, 2011
MyelomA Genetics International Consortium
Gareth Morgan, Hans Erik Johnsen, Hartmut Goldschmidt, et al.
Blood Cancer Journal
|
August 12, 2024
Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm
Charlotte Pawlyn, Fredrik H Schjesvold, David A Cairns, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 25, 2010
Phase I/II clinical study of Tosedostat, an inhibitor of aminopeptidases, in patients with acute myeloid leukemia and myelodysplasia
Bob Löwenberg, Gareth Morgan, Gert J Ossenkoppele, et al.
Blood Advances
|
August 17, 2022
Characterizing the role of the immune microenvironment in multiple myeloma progression at a single-cell level
Carolina Schinke, Alexandra M Poos, Michael Bauer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 23, 2024
Genomic Profiling to Contextualize the Results of Intervention for Smoldering Multiple Myeloma
Dickran Kazandjian, Benjamin Diamond, Marios Papadimitriou, et al.
Page
of 23